Companies / Bahrain
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
MENA Countries Still Wary Over FTAs?
October 2006 | Industry NewsSorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
The issue of Free Trade Agreements between Middle Eastern countries and the US has been under the spotlight recently, with Egypt, Qatar and the UAE all considering deals with Washington. To date, the US has agreed FTAs with Jordan, Bahrain and Oman, yet much of the MEAN region remains antagonistic to such arrangements. This is partly due to opposition to US support for Israel, but also to do with the strict conditions that the US imposes on its bilateral trading partners. In the pharmaceuticals sector, for example, US demands over intellectual property has left local generic firms -which profit from